GLB-001

A First-in-human, Phase 1, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Arms / Cohorts

Experimental:Dose Escalation: GLB-001 - AML Patients

Accepting patients

Experimental:Dose Escalation: GLB-001 - MDS Patients

Accepting patients

Experimental:Dose Expansion: GLB-001 - MDS Patients

Not yet accepting

Experimental:Dose Expansion: GLB-001 - AML Patients

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.